Literature DB >> 18484788

Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients.

Marilisa Franceschi1, Carlo Scarcelli, Valeria Niro, Davide Seripa, Anna Maria Pazienza, Giovanni Pepe, Anna Maria Colusso, Luigi Pacilli, Alberto Pilotto.   

Abstract

BACKGROUND: Drug use increases with advancing age, and in older patients it is associated with an increase in adverse drug reactions (ADRs). ADRs are a primary cause of morbidity and mortality worldwide.
OBJECTIVES: To evaluate the prevalence, clinical characteristics and avoidability of ADR-related hospital admissions in elderly patients.
METHODS: From November 2004 to December 2005, all patients aged >or=65 years consecutively admitted to the Geriatric Unit of the Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo in Italy, were evaluated for enrolment in the study. ADRs were defined according to the WHO Adverse Reaction Terminology system. Drugs were classified according to Anatomical Therapeutic Chemical classification system. The Naranjo algorithm was used to evaluate the relationship between drug use and the ADR (definite, probable, possible or doubtful) and Hallas criteria were used to evaluate the avoidability of the ADR (definitely avoidable, possibly avoidable or unavoidable). All cases of a suspected ADR were discussed by a team trained in drug safety, including three geriatricians, one clinical pharmacologist and one pharmacist. Only cases of an ADR with an agreement >or=80% were included.
RESULTS: Of the 1756 patients observed, 102 (5.8%, 42 males, 60 females, mean age 76.5 +/- 7.4 years, range 65-93 years) showed certain (6.8%) or probable (91.2%) ADR-related hospitalization. Gastrointestinal disorders (48 patients, 47.1%); platelet, bleeding and clotting disorders (20 patients, 19.6%); and cardiovascular disorders (13 patients, 12.7%) were the most frequent ADRs. NSAIDs (23.5%), oral anticoagulants (20.6%), low-dose aspirin (acetylsalicylic acid) [13.7%] and digoxin (12.7%) were the drugs most frequently involved in ADRs. Of the ADRs, 45.1% were defined as definitely avoidable, 31.4% as possibly avoidable, 18.6% as unavoidable and 4.9% as unclassifiable. Of 78 patients with definitely or possibly avoidable ADRs, 17 patients (21.8%) had received an inappropriate prescription, 29 patients (37.2%) had not received a prescription for an effective gastroprotective drug concomitantly with NSAID or low-dose aspirin treatment and 32 patients (41%) were not monitored during drug treatment.
CONCLUSION: In the elderly, almost 6% of hospitalizations are ADR related. Most of these ADRs are potentially avoidable. Strategies that reduce inappropriate prescriptions and monitoring errors, as well as improving active prevention of ADRs, are needed in elderly subjects.

Entities:  

Mesh:

Year:  2008        PMID: 18484788     DOI: 10.2165/00002018-200831060-00009

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  46 in total

1.  Oral anticoagulation and risk of death: a medical record linkage study.

Authors:  Anders Odén; Martin Fahlén
Journal:  BMJ       Date:  2002-11-09

2.  Preventable drug-related hospital admissions.

Authors:  Almut G Winterstein; Brian C Sauer; Charles D Hepler; Charles Poole
Journal:  Ann Pharmacother       Date:  2002 Jul-Aug       Impact factor: 3.154

3.  Drug-drug interactions among elderly patients hospitalized for drug toxicity.

Authors:  David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

4.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

5.  International drug monitoring: the role of national centres. Report of a WHO meeting.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1972

6.  Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients.

Authors:  J Doucet; P Chassagne; C Trivalle; I Landrin; M D Pauty; N Kadri; J F Ménard; E Bercoff
Journal:  J Am Geriatr Soc       Date:  1996-08       Impact factor: 5.562

7.  Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.

Authors:  M E Cromheecke; M Levi; L P Colly; B J de Mol; M H Prins; B A Hutten; R Mak; K C Keyzers; H R Büller
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

8.  Contribution of adverse drug reactions to hospital admission of older patients.

Authors:  C K Mannesse; F H Derkx; M A de Ridder; A J Man in 't Veld; T J van der Cammen
Journal:  Age Ageing       Date:  2000-01       Impact factor: 10.668

9.  Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases.

Authors:  P Serrano; A Lanas; M T Arroyo; I J Ferreira
Journal:  Aliment Pharmacol Ther       Date:  2002-11       Impact factor: 8.171

Review 10.  Epidemiology of adverse drug reactions in the elderly by drug class.

Authors:  R J Beyth; R I Shorr
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 4.271

View more
  70 in total

Review 1.  Potentially inappropriate medications in the elderly: a comprehensive protocol.

Authors:  Suzana Mimica Matanović; Vera Vlahovic-Palcevski
Journal:  Eur J Clin Pharmacol       Date:  2012-02-24       Impact factor: 2.953

Review 2.  Different models of frailty in predementia and dementia syndromes.

Authors:  F Panza; V Solfrizzi; V Frisardi; S Maggi; D Sancarlo; F Adante; G D'Onofrio; D Seripa; A Pilotto
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

Review 3.  Preventability of drug-related harms - part I: a systematic review.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 4.  Dysregulation of human Toll-like receptor function in aging.

Authors:  Albert C Shaw; Alexander Panda; Samit R Joshi; Feng Qian; Heather G Allore; Ruth R Montgomery
Journal:  Ageing Res Rev       Date:  2010-11-10       Impact factor: 10.895

5.  Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features.

Authors:  Consuelo Pedrós; Francesc Formiga; Xavier Corbella; Josep Maria Arnau
Journal:  Eur J Clin Pharmacol       Date:  2015-11-07       Impact factor: 2.953

Review 6.  A systematic review of hospitalization resulting from medicine-related problems in adult patients.

Authors:  Abdullah Al Hamid; Maisoon Ghaleb; Hisham Aljadhey; Zoe Aslanpour
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

7.  The SENATOR project: developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy.

Authors:  Roy L Soiza; Selvarani Subbarayan; Cherubini Antonio; Alfonso J Cruz-Jentoft; Mirko Petrovic; Adalsteinn Gudmundsson; Denis O'Mahony
Journal:  Ther Adv Drug Saf       Date:  2016-11-02

Review 8.  Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis.

Authors:  T J Oscanoa; F Lizaraso; Alfonso Carvajal
Journal:  Eur J Clin Pharmacol       Date:  2017-03-01       Impact factor: 2.953

9.  Negative clinical outcomes of medication resulting in emergency department visits.

Authors:  María Isabel Baena; Paloma C Fajardo; Antonio Pintor-Mármol; M José Faus; Rosario Marín; Antonio Zarzuelo; José Martínez-Olmos; Fernando Martínez-Martínez
Journal:  Eur J Clin Pharmacol       Date:  2013-10-03       Impact factor: 2.953

10.  Self-reported medication side effects in an older cohort living independently in the community--the Melbourne Longitudinal Study on Healthy Ageing (MELSHA): cross-sectional analysis of prevalence and risk factors.

Authors:  Jennifer A Thomson; Wei C Wang; Colette Browning; Hal L Kendig
Journal:  BMC Geriatr       Date:  2010-06-10       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.